«Therefore, any potential promising results get diluted
because novel therapies are not administered to those select patients who are most likely to respond, based on their tumors» molecular profile.
Not exact matches
This is important
because it makes it possible to model almost any autoimmune disease, evaluate new drug
therapies, and even identify
novel targets in the emerging area of cancer immunotherapies.
Because the precise activation of Hox genes is essential for a cell's fate, «the research should prove extremely useful in developing
novel embryonic stem cell - based
therapies, Mazzoni adds.
These experiments are innovative
because they seek to improve a mouse model based on current knowledge from human disease, while also testing
novel therapies that could be of benefit for affected individuals.